Aug 19, 2024, 16:12
Celebrating 25 years of impact – St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on X:
“As we celebrate 25 years of impact, we’re reminded of a key milestone from 2021: the 5-year survival rate for children with high-risk group 3 medulloblastoma increased from 54% to 73% by adding a chemotherapy drug during radiation.
Source: St. Baldrick’s Foundation/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:28
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32